Ergoteles LLC Celldex Therapeutics, Inc. Transaction History

Ergoteles LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$34.78 - $47.43 $13,598 - $18,545	-391 Reduced 1.09%	35,629 $1.28 Million
Q4 2022 Feb 14, 2023	BUY	$27.78 - $45.38 $1 Million - $1.63 Million	36,020 New	36,020 $1.61 Million
Q2 2022 Aug 12, 2022	SELL	$20.5 - $37.33 $239,891 - $436,835	-11,702 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$27.64 - $39.32 $123,246 - $175,327	-4,459 Reduced 27.59%	11,702 $399,000
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $576,624 - $909,379	16,161 New	16,161 $624,000
Q1 2021 May 12, 2021	SELL	$16.19 - $29.91 $509,985 - $942,165	-31,500 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$14.99 - $22.75 $472,185 - $716,625	31,500 New	31,500 $552,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.23B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.